DeutschNewstral
Lannett Co
- MTechnical-analysis trading: Four stocks that may be moving highermarketwatch.com
FDA gives Lannett more time to fight for generic ADHD drugbizjournals.com- Lannett nets its 10th FDA approval of 2017bizjournals.com
- FDA approves Lannett's generic dementia drugbizjournals.com
- Lannett expects to record $65M 'impairment' charge.bizjournals.com
- Generic drug maker Lannett making progress on first branded productbizjournals.com
- FDA to withdraw approval of Lannett's generic ADHD drugbizjournals.com
- Lannett plants pass FDA inspectionsbizjournals.com
- MBull trend intact, U.S. benchmarks absorb Fed-related ‘volatility’marketwatch.com
- FDA approves Lannett partner's patch for treating chronic painbizjournals.com
- $200M buyback: Lannett wiping more high-interest debt off its balance sheetbizjournals.com
- $50M debt buyback: Lannett repurchasing senior notesbizjournals.com
- Lannett & Chinese partner developing generic insulin productbizjournals.com
- Northeast Philly drug company makes a $1.2 billion acquisitionbizjournals.com
- MLannett shares jump on deal to acquire Kremers Urban Pharmamarketwatch.com
- Philadelphia drug company launches generic antidepressantbizjournals.com
Generic Drug Price Hike Investigations Target Lannettjdsupra.com- Philadelphia drug company subpoenaed, stock price fallsbizjournals.com
- Lannett defends pricing practices amid probebizjournals.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.